首页> 外文期刊>BMC Geriatrics >Opti-Med: the effectiveness of optimised clinical medication reviews in older people with ‘geriatric giants’ in general practice; study protocol of a cluster randomised controlled trial
【24h】

Opti-Med: the effectiveness of optimised clinical medication reviews in older people with ‘geriatric giants’ in general practice; study protocol of a cluster randomised controlled trial

机译:Opti-Med:在一般情况下,具有“老年病巨人”的老年人优化临床药物评论的有效性;整群随机对照试验的研究方案

获取原文
       

摘要

Background Inappropriate drug use has been identified as one of the most important problems affecting the quality of care in older people. Inappropriate drug use may increase the risk of the occurrence of ‘geriatric giants’ such as immobility, instability, incontinence and cognitive impairment. There are indications that clinical medication reviews (CMR) can reduce inappropriate drug use. However, CMRs have not yet been implemented at a large scale in primary care. An innovative medication review program in primary care will be developed which tackles the most important obstacles for a large scale implementation of CMRs. The aim of this study is to assess whether this CMR program is (cost-) effective compared with usual general practice care for older patients with geriatric symptoms with regard to quality of life and geriatric symptoms. Methods A cluster randomised controlled trial will be performed in 20 Dutch general practices including 500 patients. Patients of 65?years and older are eligible if they newly present with pre-specified geriatric symptoms in general practice and chronic use of at least one prescribed drug. GP practices will be stratified by practice size and randomly allocated to control (n?=?10) or intervention group (n?=?10). The intervention consists of CMRs which will be facilitated and prepared by an expert team consisting of a GP and a pharmacist. Primary outcome measures are patient’s quality of life and the presence of self-reported geriatric symptoms during a follow-up period of 6?months. Secondary outcomes are costs of healthcare utilisation, feasibility, number of drug related problems, medication adherence and satisfaction with medication. Discussion This study is expected to add evidence on the (cost-) effectiveness of an optimally facilitated, prepared and structured CMR in comparison with usual care in older patients who present a geriatric symptom to their GP. The strength of this study is that it will be conducted in daily clinical practice. This improves the possibilities to implement the CMRs in the primary care setting on a large scale. Trial registration Netherlands Trial register: NTR4264
机译:背景技术滥用毒品已被认为是影响老年人护理质量的最重要问题之一。滥用毒品可能会增加发生“老年病巨人”的风险,例如固定不动,不稳定,失禁和认知障碍。有迹象表明,临床药物评论(CMR)可以减少不适当的药物使用。但是,在初级保健中尚未大规模实施CMR。将制定一项创新的初级保健药物审查计划,该计划将解决大规模实施CMR的最重要障碍。这项研究的目的是就生活质量和老年症状而言,评估该CMR计划相对于具有老年症状的老年患者的常规常规护理是否(成本)有效。方法将采用20种荷兰常规实践进行一项整群随机对照试验,包括500名患者。如果65岁及以上的患者在一般实践中新出现预先指定的老年症状并长期使用至少一种处方药,则符合资格。 GP实践将按实践规模进行分层,并随机分配给对照组(n = 10)或干预组(n = 10)。干预措施包括CMR,由GP和药剂师组成的专家团队将协助和准备CMR。主要结局指标是患者的生活质量以及在6个月的随访期内是否出现自我报告的老年症状。次要结果是医疗保健利用成本,可行性,与药物相关的问题数量,药物依从性和药物满意度。讨论预期该研究将为在GP上出现老年症状的老年患者与常规治疗相比,提供最佳便利,准备和结构化CMR的(成本)有效性的证据。这项研究的优势在于它将在日常临床实践中进行。这提高了在基层医疗机构大规模实施CMR的可能性。试用注册荷兰试用注册:NTR4264

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号